Kanchanatawan, Buranee <br/><br/>
The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.  [electronic resource] 

 -  CNS & neurological disorders drug targets  2018 
 - 473-486 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1996-3181 
<br/><br/><label>Standard No.: </label>10.2174/1871527317666180702160921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Cognition Disorders--etiology<br/>Executive Function--physiology<br/>Female<br/>Humans<br/>Immunoglobulin A--immunology<br/>Immunoglobulin M--immunology<br/>Kynurenic Acid--metabolism<br/>Kynurenine--metabolism<br/>Kynurenine 3-Monooxygenase--metabolism<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Picolinic Acids--metabolism<br/>Psychiatric Status Rating Scales<br/>Quinolinic Acid--metabolism<br/>Schizophrenia--complications<br/>Schizophrenic Psychology<br/>Tryptophan--immunology<br/>Xanthurenates--metabolism<br/>Young Adult